Literature DB >> 15138717

Expression of IAP family proteins in colon cancers from patients with different age groups.

T Endo1, S Abe, H B K Seidlar, S Nagaoka, T Takemura, M Utsuyama, M Kitagawa, K Hirokawa.   

Abstract

Members of the inhibitor of apoptosis protein (IAP) family including survivin, are expressed in many tumors. However, age-related changes in their expression in cancer have not been clarified. Thus, we investigated the expression of mRNA-coding for IAP family proteins in colon cancer samples from young (<70 years of age) and elderly (>70 years) patients by real-time quantitative RT-PCR. Samples were collected from cases with well-differentiated adenocarcinoma or moderately differentiated adenocarcinoma and their adjacent normal epithelial tissue. Well-differentiated adenocarcinoma tended to express higher levels of survivin than normal mucosa, and expression in moderately differentiated adenocarcinoma was significantly greater than in normal mucosa in samples from both groups of patients ( p<0.05, respectively). When samples were compared between the different age groups, the normal mucosa exhibited similar levels of survivin expression. However, samples from older patients showed a significantly higher level of expression than those from younger patients in well and moderately differentiated adenocarcinomas ( p<0.05, respectively). In contrast, the levels of expression of cIAP1, cIAP2, and NAIP in the cancerous tissues were lower than those found in normal mucosa regardless of age. As for age-related changes, the expression of cIAP2 in normal mucosa and moderately differentiated adenocarcinoma was stronger in the elderly group than the young group ( p<0.05, respectively), and NAIP expression in well-differentiated adenocarcinoma was higher in the young group than the elderly group ( p<0.05). XIAP expression was similar in normal and cancerous tissues in both the young and elderly groups. These results suggest that the expression of IAP family proteins, especially survivin, is associated with the age-related biological characteristics of colon cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15138717     DOI: 10.1007/s00262-004-0534-8

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  23 in total

Review 1.  Inflammasomes and intestinal inflammation.

Authors:  N Zmora; M Levy; M Pevsner-Fishcer; E Elinav
Journal:  Mucosal Immunol       Date:  2017-04-12       Impact factor: 7.313

2.  Association of XIAP and P2X7 receptor expression with lymph node metastasis in papillary thyroid carcinoma.

Authors:  Li-Qun Gu; Feng-Ying Li; Lin Zhao; Yun Liu; Qian Chu; Xun-Xiong Zang; Jian-Min Liu; Guang Ning; Yong-Ju Zhao
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

Review 3.  Inhibitor of apoptosis protein family as diagnostic markers and therapeutic targets of colorectal cancer.

Authors:  Koh Miura; Wataru Fujibuchi; Kazuyuki Ishida; Takeshi Naitoh; Hitoshi Ogawa; Toshinori Ando; Nobuki Yazaki; Kazuhiro Watanabe; Sho Haneda; Chikashi Shibata; Iwao Sasaki
Journal:  Surg Today       Date:  2011-01-26       Impact factor: 2.549

4.  Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein.

Authors:  Collins A Karikari; Indrajit Roy; Eric Tryggestad; Georg Feldmann; Clemencia Pinilla; Kate Welsh; John C Reed; Elwood P Armour; John Wong; Joseph Herman; Dinesh Rakheja; Anirban Maitra
Journal:  Mol Cancer Ther       Date:  2007-03-05       Impact factor: 6.261

5.  Gene signature distinguishes patients with chronic ulcerative colitis harboring remote neoplastic lesions.

Authors:  Joel Pekow; Urszula Dougherty; Yong Huang; Edward Gometz; Jeff Nathanson; Greg Cohen; Shawn Levy; Masha Kocherginsky; Nanda Venu; Maria Westerhoff; John Hart; Amy E Noffsinger; Stephen B Hanauer; Roger D Hurst; Alessandro Fichera; Loren J Joseph; Qiang Liu; Marc Bissonnette
Journal:  Inflamm Bowel Dis       Date:  2013-03       Impact factor: 5.325

6.  High expression of Foxp3, IL-23p19 and survivin mRNA in colorectal carcinoma.

Authors:  Noyko Stanilov; Lyuba Miteva; Nikolay Mintchev; Spaska Stanilova
Journal:  Int J Colorectal Dis       Date:  2008-09-30       Impact factor: 2.571

7.  Expression profiles of proliferative and antiapoptotic genes in sporadic and colitis-related mouse colon cancer models.

Authors:  Jirí Svec; Peter Ergang; Václav Mandys; Milan Kment; Jirí Pácha
Journal:  Int J Exp Pathol       Date:  2010-02       Impact factor: 1.925

8.  Mechanistic roles of epithelial and immune cell signaling during the development of colitis-associated cancer.

Authors:  Renuka Subramaniam; Atsushi Mizoguchi; Emiko Mizoguchi
Journal:  Cancer Res Front       Date:  2016-01-21

9.  Upregulation of the antiapoptotic factor Livin contributes to cisplatin resistance in colon cancer cells.

Authors:  Zhen-Yu Ding; Gui-Hong Liu; Birgit Olsson; Xiao-Feng Sun
Journal:  Tumour Biol       Date:  2012-11-28

10.  Role of IAPs in prostate cancer progression: immunohistochemical study in normal and pathological (benign hyperplastic, prostatic intraepithelial neoplasia and cancer) human prostate.

Authors:  Gonzalo Rodríguez-Berriguete; Benito Fraile; Fermín R de Bethencourt; Angela Prieto-Folgado; Nahikari Bartolome; Claudia Nuñez; Bruna Prati; Pilar Martínez-Onsurbe; Gabriel Olmedilla; Ricardo Paniagua; Mar Royuela
Journal:  BMC Cancer       Date:  2010-01-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.